NCT06788418 Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction
| NCT ID | NCT06788418 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Visionly Plus Eye Hospital |
| Condition | Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2025-01-20 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18-40 years * Spherical equivalent of -1.00 to -10.00 D * Stable refraction for at least 12 months * Informed consent provided Exclusion Criteria: * Other ocular pathologies * Previous refractive surgery * Pregnancy or nursing * Autoimmune or connective tissue disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06788418 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06788418 currently recruiting?
Yes, NCT06788418 is actively recruiting participants. Contact the research team at drzhoupeng@gmail.com for enrollment information.
Where is the NCT06788418 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China.
Who is sponsoring the NCT06788418 clinical trial?
NCT06788418 is sponsored by Beijing Visionly Plus Eye Hospital. The trial plans to enroll 1,000 participants.